Gene Symbol | Gene ID | Gene Info |
---|---|---|
ALX3
|
ENSG00000156150.6 | ALX homeobox 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_110612344_110612495 | ALX3 | 903 | 0.464969 | -0.84 | 4.2e-03 | Click! |
chr1_110612181_110612332 | ALX3 | 1066 | 0.399849 | -0.70 | 3.4e-02 | Click! |
chr1_110611207_110611387 | ALX3 | 2025 | 0.221997 | -0.51 | 1.6e-01 | Click! |
chr1_110610670_110610821 | ALX3 | 2577 | 0.185894 | -0.49 | 1.8e-01 | Click! |
chr1_110611840_110612052 | ALX3 | 1376 | 0.313655 | -0.48 | 1.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_178102702_178103151 | 1.64 |
RASAL2 |
RAS protein activator like 2 |
39650 |
0.22 |
chr5_81460698_81461288 | 1.40 |
ENSG00000265684 |
. |
86747 |
0.08 |
chr15_59641636_59642058 | 1.30 |
ENSG00000199512 |
. |
8231 |
0.13 |
chr9_14205951_14206102 | 1.29 |
NFIB |
nuclear factor I/B |
25229 |
0.27 |
chr11_126515519_126515813 | 1.27 |
RP11-115C10.1 |
|
7081 |
0.29 |
chr12_10344371_10344522 | 1.14 |
TMEM52B |
transmembrane protein 52B |
12333 |
0.12 |
chr11_33934050_33934291 | 1.09 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
20334 |
0.2 |
chr4_114304726_114304877 | 1.06 |
ANK2 |
ankyrin 2, neuronal |
10286 |
0.22 |
chr16_24742094_24743166 | 1.04 |
TNRC6A |
trinucleotide repeat containing 6A |
1596 |
0.5 |
chr7_115994446_115994930 | 1.02 |
ENSG00000216076 |
. |
8690 |
0.21 |
chr5_66255925_66256427 | 1.02 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
1360 |
0.56 |
chr9_75764547_75765336 | 0.99 |
ANXA1 |
annexin A1 |
1732 |
0.5 |
chr6_56591218_56591369 | 0.98 |
DST |
dystonin |
59384 |
0.15 |
chr5_139626504_139626769 | 0.98 |
CTB-131B5.2 |
|
46888 |
0.09 |
chr5_71683529_71683680 | 0.97 |
RP11-389C8.2 |
|
54610 |
0.12 |
chr14_74724538_74725207 | 0.94 |
VSX2 |
visual system homeobox 2 |
18697 |
0.14 |
chr18_72443447_72443598 | 0.93 |
ZNF407 |
zinc finger protein 407 |
100546 |
0.08 |
chr9_130302299_130302610 | 0.92 |
FAM129B |
family with sequence similarity 129, member B |
28913 |
0.13 |
chr1_92311778_92311983 | 0.92 |
TGFBR3 |
transforming growth factor, beta receptor III |
15270 |
0.21 |
chr21_39659541_39659821 | 0.91 |
KCNJ15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
8798 |
0.29 |
chr10_65024052_65024675 | 0.89 |
JMJD1C |
jumonji domain containing 1C |
4463 |
0.31 |
chr20_39919427_39919896 | 0.88 |
ENSG00000263989 |
. |
444 |
0.84 |
chr3_177553335_177553655 | 0.88 |
ENSG00000199858 |
. |
172072 |
0.04 |
chr4_95470032_95470452 | 0.87 |
PDLIM5 |
PDZ and LIM domain 5 |
25366 |
0.27 |
chr9_4137653_4137928 | 0.86 |
GLIS3 |
GLIS family zinc finger 3 |
7403 |
0.28 |
chr2_60758944_60759403 | 0.85 |
BCL11A |
B-cell CLL/lymphoma 11A (zinc finger protein) |
21367 |
0.21 |
chr12_95597054_95597379 | 0.84 |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
13939 |
0.18 |
chr1_227379724_227379875 | 0.83 |
RP11-1B20.1 |
|
13765 |
0.27 |
chr7_102532238_102532538 | 0.83 |
LRRC17 |
leucine rich repeat containing 17 |
21050 |
0.16 |
chr8_143757168_143757384 | 0.83 |
PSCA |
prostate stem cell antigen |
4598 |
0.13 |
chr4_78502666_78502963 | 0.82 |
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
69907 |
0.13 |
chr18_60117683_60118024 | 0.81 |
ZCCHC2 |
zinc finger, CCHC domain containing 2 |
72387 |
0.1 |
chr3_154604594_154604879 | 0.81 |
MME |
membrane metallo-endopeptidase |
137177 |
0.05 |
chr9_117877775_117877926 | 0.81 |
TNC |
tenascin C |
2628 |
0.36 |
chr11_101316813_101316964 | 0.80 |
ENSG00000263885 |
. |
73748 |
0.12 |
chr6_17972496_17972680 | 0.80 |
KIF13A |
kinesin family member 13A |
15106 |
0.27 |
chr3_126721307_126721580 | 0.80 |
PLXNA1 |
plexin A1 |
14006 |
0.29 |
chr6_17906953_17907342 | 0.80 |
KIF13A |
kinesin family member 13A |
80547 |
0.1 |
chr17_29906221_29906372 | 0.80 |
ENSG00000199187 |
. |
3866 |
0.14 |
chr1_109740426_109740857 | 0.80 |
ENSG00000238310 |
. |
9829 |
0.15 |
chr12_48163883_48164256 | 0.80 |
RAPGEF3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
748 |
0.49 |
chr13_110651559_110651710 | 0.79 |
ENSG00000201161 |
. |
84191 |
0.1 |
chr5_14154020_14154339 | 0.79 |
TRIO |
trio Rho guanine nucleotide exchange factor |
10350 |
0.32 |
chr14_69555636_69555913 | 0.79 |
ENSG00000206768 |
. |
54896 |
0.12 |
chr9_21383132_21383283 | 0.79 |
IFNA2 |
interferon, alpha 2 |
2189 |
0.22 |
chr4_102023966_102024184 | 0.78 |
ENSG00000221265 |
. |
227496 |
0.02 |
chr2_62987338_62987489 | 0.78 |
ENSG00000252436 |
. |
33538 |
0.18 |
chr14_75805696_75805973 | 0.77 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
58938 |
0.09 |
chr7_41909334_41909592 | 0.77 |
AC005027.3 |
|
164530 |
0.04 |
chr16_72928505_72928656 | 0.77 |
ENSG00000251868 |
. |
72689 |
0.09 |
chr6_144587139_144587431 | 0.77 |
UTRN |
utrophin |
19552 |
0.24 |
chr18_10213374_10213664 | 0.77 |
ENSG00000239031 |
. |
176478 |
0.03 |
chr3_81777841_81778131 | 0.76 |
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
14794 |
0.31 |
chr4_86683324_86683672 | 0.76 |
ARHGAP24 |
Rho GTPase activating protein 24 |
16361 |
0.24 |
chr11_111848937_111849153 | 0.75 |
DIXDC1 |
DIX domain containing 1 |
1012 |
0.41 |
chr16_20917135_20917548 | 0.75 |
LYRM1 |
LYR motif containing 1 |
4915 |
0.18 |
chr12_1727335_1727720 | 0.75 |
WNT5B |
wingless-type MMTV integration site family, member 5B |
1305 |
0.46 |
chr9_3508480_3509240 | 0.75 |
RFX3 |
regulatory factor X, 3 (influences HLA class II expression) |
17123 |
0.25 |
chr1_25666704_25667414 | 0.75 |
ENSG00000252515 |
. |
403 |
0.75 |
chr4_170175475_170175626 | 0.75 |
SH3RF1 |
SH3 domain containing ring finger 1 |
15558 |
0.25 |
chr8_38264429_38264741 | 0.74 |
RP11-350N15.6 |
|
1675 |
0.23 |
chr1_173159483_173159962 | 0.74 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
14975 |
0.26 |
chr1_183776609_183776992 | 0.74 |
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1 |
2510 |
0.36 |
chr15_78594610_78594888 | 0.74 |
WDR61 |
WD repeat domain 61 |
2613 |
0.18 |
chr8_142158040_142158331 | 0.73 |
DENND3 |
DENN/MADD domain containing 3 |
6883 |
0.21 |
chr6_106544357_106545290 | 0.73 |
PRDM1 |
PR domain containing 1, with ZNF domain |
1658 |
0.4 |
chr7_137276747_137277035 | 0.73 |
PTN |
pleiotrophin |
248280 |
0.02 |
chr3_98481605_98482039 | 0.73 |
ST3GAL6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
339 |
0.89 |
chr4_114394825_114395109 | 0.73 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
40031 |
0.16 |
chr3_111431650_111431801 | 0.72 |
PHLDB2 |
pleckstrin homology-like domain, family B, member 2 |
19619 |
0.18 |
chr10_125793430_125793581 | 0.72 |
CHST15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
12736 |
0.27 |
chr6_42891155_42891426 | 0.72 |
CNPY3 |
canopy FGF signaling regulator 3 |
5648 |
0.11 |
chr10_54079967_54080118 | 0.72 |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
5986 |
0.26 |
chr2_153267355_153267720 | 0.72 |
FMNL2 |
formin-like 2 |
75786 |
0.12 |
chr1_170532826_170532977 | 0.72 |
RP11-576I22.2 |
|
31113 |
0.19 |
chr10_22014116_22014329 | 0.71 |
MLLT10 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
51715 |
0.13 |
chr1_235242449_235242943 | 0.71 |
ENSG00000207181 |
. |
48556 |
0.13 |
chr15_93448618_93449297 | 0.71 |
CHD2 |
chromodomain helicase DNA binding protein 2 |
1254 |
0.36 |
chr6_113424091_113424381 | 0.71 |
ENSG00000201386 |
. |
131541 |
0.06 |
chr13_60664906_60665057 | 0.71 |
DIAPH3-AS2 |
DIAPH3 antisense RNA 2 |
53851 |
0.12 |
chr12_13327377_13327528 | 0.71 |
EMP1 |
epithelial membrane protein 1 |
22198 |
0.21 |
chr3_177443249_177443545 | 0.71 |
ENSG00000200288 |
. |
101200 |
0.08 |
chr3_174159594_174160082 | 0.71 |
NAALADL2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
1061 |
0.7 |
chr10_102288134_102289261 | 0.70 |
HIF1AN |
hypoxia inducible factor 1, alpha subunit inhibitor |
132 |
0.88 |
chr11_109870547_109870746 | 0.70 |
ZC3H12C |
zinc finger CCCH-type containing 12C |
93441 |
0.1 |
chr3_55558379_55558651 | 0.70 |
WNT5A |
wingless-type MMTV integration site family, member 5A |
34542 |
0.2 |
chr11_126788305_126788456 | 0.70 |
KIRREL3-AS2 |
KIRREL3 antisense RNA 2 |
22262 |
0.2 |
chrX_39832066_39832217 | 0.70 |
BCOR |
BCL6 corepressor |
90049 |
0.09 |
chr9_94178983_94179134 | 0.70 |
NFIL3 |
nuclear factor, interleukin 3 regulated |
7086 |
0.3 |
chr6_3473042_3473193 | 0.70 |
SLC22A23 |
solute carrier family 22, member 23 |
15861 |
0.27 |
chr3_171531596_171531819 | 0.70 |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
3423 |
0.23 |
chr12_27674156_27674440 | 0.70 |
PPFIBP1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
2066 |
0.37 |
chr7_1462493_1462644 | 0.70 |
MICALL2 |
MICAL-like 2 |
36394 |
0.13 |
chr18_55854122_55854396 | 0.70 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
8363 |
0.23 |
chr12_109060942_109061130 | 0.69 |
ENSG00000238457 |
. |
1188 |
0.4 |
chr2_54697560_54697817 | 0.69 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
13290 |
0.24 |
chr13_76299059_76299210 | 0.69 |
LMO7 |
LIM domain 7 |
35369 |
0.19 |
chr10_62186857_62187008 | 0.69 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
37444 |
0.23 |
chr17_28275117_28275440 | 0.69 |
EFCAB5 |
EF-hand calcium binding domain 5 |
6655 |
0.17 |
chr12_54652947_54653855 | 0.69 |
CBX5 |
chromobox homolog 5 |
25 |
0.94 |
chr4_170069367_170069518 | 0.69 |
RP11-327O17.2 |
|
53503 |
0.15 |
chr4_128619906_128620188 | 0.69 |
INTU |
inturned planar cell polarity protein |
11078 |
0.23 |
chr6_2103859_2104525 | 0.68 |
GMDS |
GDP-mannose 4,6-dehydratase |
72033 |
0.13 |
chr4_169526190_169526341 | 0.68 |
PALLD |
palladin, cytoskeletal associated protein |
26501 |
0.19 |
chr8_93978348_93978807 | 0.68 |
TRIQK |
triple QxxK/R motif containing |
204 |
0.96 |
chr2_205613830_205613981 | 0.68 |
PARD3B |
par-3 family cell polarity regulator beta |
203182 |
0.03 |
chr5_135353062_135353213 | 0.68 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
11447 |
0.21 |
chr9_90215657_90216062 | 0.68 |
DAPK1-IT1 |
DAPK1 intronic transcript 1 (non-protein coding) |
47490 |
0.16 |
chr17_76911354_76911505 | 0.68 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
7054 |
0.15 |
chr11_3980211_3980997 | 0.68 |
STIM1 |
stromal interaction molecule 1 |
12031 |
0.18 |
chr6_82477389_82477689 | 0.68 |
ENSG00000206886 |
. |
3798 |
0.25 |
chr3_149058191_149058568 | 0.67 |
TM4SF18 |
transmembrane 4 L six family member 18 |
6178 |
0.2 |
chr1_234667803_234667954 | 0.67 |
TARBP1 |
TAR (HIV-1) RNA binding protein 1 |
53029 |
0.12 |
chr8_38266802_38267077 | 0.67 |
RP11-350N15.6 |
|
679 |
0.57 |
chr1_25096598_25097084 | 0.67 |
ENSG00000238482 |
. |
7629 |
0.22 |
chr9_127458223_127458492 | 0.67 |
ENSG00000207737 |
. |
2368 |
0.24 |
chr1_31870163_31870721 | 0.67 |
SERINC2 |
serine incorporator 2 |
11970 |
0.15 |
chr6_121968926_121969077 | 0.67 |
ENSG00000222659 |
. |
67334 |
0.13 |
chr7_77496191_77496692 | 0.67 |
PHTF2 |
putative homeodomain transcription factor 2 |
26944 |
0.18 |
chr22_26717807_26718076 | 0.67 |
SEZ6L |
seizure related 6 homolog (mouse)-like |
25740 |
0.18 |
chr2_36588027_36588178 | 0.67 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
4488 |
0.34 |
chr4_10009068_10009219 | 0.66 |
RP11-448G15.1 |
|
1037 |
0.53 |
chr3_99203528_99203679 | 0.66 |
ENSG00000266030 |
. |
117870 |
0.06 |
chr12_32268914_32269294 | 0.66 |
RP11-843B15.2 |
|
8642 |
0.23 |
chr20_19232926_19233221 | 0.66 |
RP5-1027G4.3 |
|
32167 |
0.16 |
chr12_66296581_66296811 | 0.66 |
RP11-366L20.2 |
Uncharacterized protein |
20749 |
0.16 |
chr12_71040223_71040434 | 0.66 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
9108 |
0.29 |
chr12_78453632_78453897 | 0.66 |
RP11-136F16.1 |
|
31753 |
0.23 |
chr18_6730887_6731038 | 0.66 |
ARHGAP28 |
Rho GTPase activating protein 28 |
920 |
0.46 |
chr6_15349427_15349643 | 0.66 |
ENSG00000201519 |
. |
24832 |
0.19 |
chr8_37397688_37397839 | 0.66 |
RP11-150O12.6 |
|
23224 |
0.22 |
chr4_114706244_114706541 | 0.66 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
23309 |
0.27 |
chr6_85293592_85293821 | 0.65 |
RP11-132M7.3 |
|
105437 |
0.08 |
chr12_120131477_120131628 | 0.65 |
RP1-127H14.3 |
Uncharacterized protein |
6021 |
0.18 |
chr5_58904865_58905027 | 0.65 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
22621 |
0.27 |
chr1_109632204_109632387 | 0.65 |
TMEM167B |
transmembrane protein 167B |
130 |
0.91 |
chr6_126135548_126136266 | 0.65 |
NCOA7 |
nuclear receptor coactivator 7 |
457 |
0.81 |
chr1_178027486_178027784 | 0.65 |
RASAL2 |
RAS protein activator like 2 |
35229 |
0.22 |
chr1_87801300_87801913 | 0.65 |
LMO4 |
LIM domain only 4 |
4255 |
0.35 |
chr8_141734362_141734513 | 0.65 |
PTK2 |
protein tyrosine kinase 2 |
2550 |
0.32 |
chr12_89549700_89550075 | 0.65 |
ENSG00000238302 |
. |
126175 |
0.06 |
chr3_43749805_43750085 | 0.65 |
ABHD5 |
abhydrolase domain containing 5 |
3254 |
0.31 |
chr15_40012595_40012873 | 0.65 |
RP11-37C7.3 |
|
62038 |
0.1 |
chr7_41910301_41910559 | 0.65 |
AC005027.3 |
|
165497 |
0.04 |
chr4_39152584_39152984 | 0.64 |
RP11-360F5.1 |
|
24346 |
0.17 |
chr6_5036424_5036575 | 0.64 |
ENSG00000252419 |
. |
9836 |
0.21 |
chr18_39572364_39572515 | 0.64 |
PIK3C3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
32856 |
0.26 |
chr5_39411940_39412091 | 0.64 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
12955 |
0.26 |
chr12_89339824_89340184 | 0.64 |
ENSG00000238302 |
. |
336058 |
0.01 |
chr7_98737042_98737396 | 0.64 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
4423 |
0.27 |
chr2_66783331_66783502 | 0.64 |
MEIS1 |
Meis homeobox 1 |
47357 |
0.17 |
chr11_44977228_44977439 | 0.64 |
TP53I11 |
tumor protein p53 inducible protein 11 |
4725 |
0.3 |
chr12_26303323_26303715 | 0.64 |
SSPN |
sarcospan |
15619 |
0.18 |
chr12_98834191_98834342 | 0.64 |
ENSG00000201296 |
. |
22450 |
0.18 |
chr2_40510156_40510307 | 0.64 |
AC007377.1 |
|
22084 |
0.23 |
chr1_10463771_10463989 | 0.64 |
PGD |
phosphogluconate dehydrogenase |
4191 |
0.14 |
chr18_10213675_10214158 | 0.64 |
ENSG00000239031 |
. |
176081 |
0.03 |
chr5_15249746_15249921 | 0.64 |
ENSG00000202269 |
. |
138804 |
0.05 |
chr18_456798_457125 | 0.63 |
RP11-720L2.2 |
|
32545 |
0.16 |
chr1_110779162_110779313 | 0.63 |
KCNC4 |
potassium voltage-gated channel, Shaw-related subfamily, member 4 |
25115 |
0.11 |
chr2_216372275_216372914 | 0.63 |
AC012462.1 |
|
71618 |
0.11 |
chr5_158448429_158448934 | 0.63 |
CTD-2363C16.2 |
|
35867 |
0.17 |
chr16_69092445_69092596 | 0.63 |
HAS3 |
hyaluronan synthase 3 |
46947 |
0.1 |
chr2_118804547_118804712 | 0.63 |
ENSG00000243510 |
. |
30671 |
0.13 |
chr8_91783068_91783219 | 0.63 |
NECAB1 |
N-terminal EF-hand calcium binding protein 1 |
20635 |
0.19 |
chr10_114284706_114284857 | 0.63 |
VTI1A |
vesicle transport through interaction with t-SNAREs 1A |
77765 |
0.08 |
chr18_70676877_70677028 | 0.63 |
NETO1 |
neuropilin (NRP) and tolloid (TLL)-like 1 |
141768 |
0.05 |
chr9_117440715_117440866 | 0.63 |
ENSG00000272241 |
. |
61963 |
0.1 |
chr1_95009721_95009872 | 0.63 |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
2440 |
0.41 |
chr11_10323628_10323837 | 0.63 |
RP11-351I24.1 |
|
1519 |
0.31 |
chr9_124161266_124161489 | 0.63 |
RP11-162D16.2 |
|
23858 |
0.15 |
chr9_133720557_133720776 | 0.63 |
ABL1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
10213 |
0.21 |
chr1_98470691_98470842 | 0.62 |
ENSG00000225206 |
. |
40141 |
0.21 |
chr8_118411718_118411869 | 0.62 |
ENSG00000252852 |
. |
86026 |
0.1 |
chr13_47317430_47317715 | 0.62 |
ESD |
esterase D |
38131 |
0.19 |
chr3_99751569_99751720 | 0.62 |
ENSG00000264897 |
. |
68402 |
0.1 |
chr8_33429925_33430219 | 0.62 |
RNF122 |
ring finger protein 122 |
5429 |
0.16 |
chr9_19119177_19119410 | 0.62 |
PLIN2 |
perilipin 2 |
8181 |
0.13 |
chr2_226983987_226984250 | 0.62 |
ENSG00000263363 |
. |
539391 |
0.0 |
chr8_108235226_108235555 | 0.62 |
ENSG00000211995 |
. |
31336 |
0.25 |
chr6_25005285_25005494 | 0.62 |
ENSG00000244618 |
. |
26121 |
0.17 |
chr6_140365426_140365577 | 0.62 |
ENSG00000252107 |
. |
114330 |
0.07 |
chr4_187765207_187765358 | 0.62 |
ENSG00000252382 |
. |
13328 |
0.29 |
chr16_50059665_50060650 | 0.61 |
CNEP1R1 |
CTD nuclear envelope phosphatase 1 regulatory subunit 1 |
86 |
0.97 |
chr2_46325558_46325709 | 0.61 |
AC017006.2 |
|
19666 |
0.24 |
chr3_179166483_179166634 | 0.61 |
GNB4 |
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
2375 |
0.29 |
chr9_72930623_72930774 | 0.61 |
ENSG00000239180 |
. |
4081 |
0.27 |
chr5_38807719_38807870 | 0.61 |
RP11-122C5.3 |
|
24112 |
0.22 |
chr2_36588993_36589144 | 0.61 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
5454 |
0.33 |
chr13_72218273_72218424 | 0.61 |
DACH1 |
dachshund homolog 1 (Drosophila) |
222559 |
0.02 |
chr8_117174421_117174572 | 0.61 |
ENSG00000221793 |
. |
25498 |
0.26 |
chr13_98867933_98868084 | 0.61 |
ENSG00000263399 |
. |
7230 |
0.16 |
chr1_214721687_214721838 | 0.61 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
2804 |
0.37 |
chr4_86665017_86665168 | 0.61 |
ENSG00000266421 |
. |
21471 |
0.23 |
chr3_186005888_186006039 | 0.61 |
DGKG |
diacylglycerol kinase, gamma 90kDa |
7460 |
0.29 |
chr22_33108393_33108637 | 0.61 |
LL22NC01-116C6.1 |
|
70648 |
0.1 |
chr2_174862628_174862955 | 0.61 |
SP3 |
Sp3 transcription factor |
32361 |
0.24 |
chr8_95236664_95236815 | 0.61 |
CDH17 |
cadherin 17, LI cadherin (liver-intestine) |
7208 |
0.25 |
chr4_106008618_106008769 | 0.60 |
ENSG00000252136 |
. |
18451 |
0.23 |
chr6_114196551_114196945 | 0.60 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
18207 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.4 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.2 | 0.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.8 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.3 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.2 | 1.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.5 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 1.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.6 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.5 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.8 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.7 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.7 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.1 | 0.3 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.6 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.2 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.2 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.3 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.1 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.3 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.3 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.3 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.1 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.3 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.2 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.1 | 0.4 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.2 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.5 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.5 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.2 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.7 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.2 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.0 | 0.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.0 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.0 | 0.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.4 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.0 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.2 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.0 | 0.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.0 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 1.2 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.0 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.0 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.4 | GO:0060840 | artery morphogenesis(GO:0048844) artery development(GO:0060840) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.6 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.0 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.0 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.7 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0010878 | cholesterol storage(GO:0010878) |
0.0 | 0.3 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0048820 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:2000193 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) icosanoid secretion(GO:0032309) prostaglandin secretion(GO:0032310) positive regulation of fatty acid transport(GO:2000193) |
0.0 | 0.6 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.1 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.0 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:0072141 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) kidney smooth muscle tissue development(GO:0072194) pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.1 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.3 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.2 | GO:0001841 | neural tube formation(GO:0001841) |
0.0 | 0.1 | GO:0043302 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.0 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0051135 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.2 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.0 | GO:0060026 | convergent extension(GO:0060026) |
0.0 | 0.3 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.0 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.1 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.4 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.3 | GO:0048489 | synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.2 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.1 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.2 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.0 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.0 | GO:0046449 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.1 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.6 | GO:0042552 | myelination(GO:0042552) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0017145 | stem cell division(GO:0017145) |
0.0 | 0.2 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.3 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.1 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.0 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.0 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.1 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.3 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:1901571 | prostaglandin transport(GO:0015732) icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0044247 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.0 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.0 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.0 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) adenine nucleotide transport(GO:0051503) |
0.0 | 0.2 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.0 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.8 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 1.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.1 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 3.0 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.3 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.7 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 1.0 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 3.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.9 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.3 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.3 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.0 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 0.8 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.2 | 0.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.6 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.2 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.6 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 1.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.0 | 0.4 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 1.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.0 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.2 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.0 | 0.2 | GO:0048019 | receptor inhibitor activity(GO:0030547) receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.0 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.1 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 4.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 4.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 2.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |